|
1
|
Fournier PE, Edouard S, Wurtz N, Raclot J, Bechet M, Zandotti C, Filosa V, Raoult D, Fenollar F. Contagion Management at the Méditerranée Infection University Hospital Institute. J Clin Med 2021; 10:jcm10122627. [PMID: 34203657 PMCID: PMC8232197 DOI: 10.3390/jcm10122627] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2021] [Revised: 06/09/2021] [Accepted: 06/11/2021] [Indexed: 12/21/2022] Open
Abstract
The Méditerranée Infection University Hospital Institute (IHU) is located in a recent building, which includes experts on a wide range of infectious disease. The IHU strategy is to develop innovative tools, including epidemiological monitoring, point-of-care laboratories, and the ability to mass screen the population. In this study, we review the strategy and guidelines proposed by the IHU and its application to the COVID-19 pandemic and summarise the various challenges it raises. Early diagnosis enables contagious patients to be isolated and treatment to be initiated at an early stage to reduce the microbial load and contagiousness. In the context of the COVID-19 pandemic, we had to deal with a shortage of personal protective equipment and reagents and a massive influx of patients. Between 27 January 2020 and 5 January 2021, 434,925 nasopharyngeal samples were tested for the presence of SARS-CoV-2. Of them, 12,055 patients with COVID-19 were followed up in our out-patient clinic, and 1888 patients were hospitalised in the Institute. By constantly adapting our strategy to the ongoing situation, the IHU has succeeded in expanding and upgrading its equipment and improving circuits and flows to better manage infected patients.
Collapse
Affiliation(s)
- Pierre-Edouard Fournier
- IHU-Méditerranée Infection, 19–21 Boulevard Jean Moulin, 13005 Marseille, France; (P.-E.F.); (S.E.); (N.W.); (J.R.); (M.B.); (C.Z.); (V.F.); (D.R.)
- VITROME Unit, IRD, AP-HM, SSA, IHU-Méditerranée Infection, Aix Marseille University, 13005 Marseille, France
| | - Sophie Edouard
- IHU-Méditerranée Infection, 19–21 Boulevard Jean Moulin, 13005 Marseille, France; (P.-E.F.); (S.E.); (N.W.); (J.R.); (M.B.); (C.Z.); (V.F.); (D.R.)
- MEPHI Unit, IRD, AP-HM, IHU Méditerranée Infection, Aix Marseille University, 13005 Marseille, France
| | - Nathalie Wurtz
- IHU-Méditerranée Infection, 19–21 Boulevard Jean Moulin, 13005 Marseille, France; (P.-E.F.); (S.E.); (N.W.); (J.R.); (M.B.); (C.Z.); (V.F.); (D.R.)
- VITROME Unit, IRD, AP-HM, SSA, IHU-Méditerranée Infection, Aix Marseille University, 13005 Marseille, France
| | - Justine Raclot
- IHU-Méditerranée Infection, 19–21 Boulevard Jean Moulin, 13005 Marseille, France; (P.-E.F.); (S.E.); (N.W.); (J.R.); (M.B.); (C.Z.); (V.F.); (D.R.)
| | - Marion Bechet
- IHU-Méditerranée Infection, 19–21 Boulevard Jean Moulin, 13005 Marseille, France; (P.-E.F.); (S.E.); (N.W.); (J.R.); (M.B.); (C.Z.); (V.F.); (D.R.)
| | - Christine Zandotti
- IHU-Méditerranée Infection, 19–21 Boulevard Jean Moulin, 13005 Marseille, France; (P.-E.F.); (S.E.); (N.W.); (J.R.); (M.B.); (C.Z.); (V.F.); (D.R.)
| | - Véronique Filosa
- IHU-Méditerranée Infection, 19–21 Boulevard Jean Moulin, 13005 Marseille, France; (P.-E.F.); (S.E.); (N.W.); (J.R.); (M.B.); (C.Z.); (V.F.); (D.R.)
| | - Didier Raoult
- IHU-Méditerranée Infection, 19–21 Boulevard Jean Moulin, 13005 Marseille, France; (P.-E.F.); (S.E.); (N.W.); (J.R.); (M.B.); (C.Z.); (V.F.); (D.R.)
- MEPHI Unit, IRD, AP-HM, IHU Méditerranée Infection, Aix Marseille University, 13005 Marseille, France
| | - Florence Fenollar
- IHU-Méditerranée Infection, 19–21 Boulevard Jean Moulin, 13005 Marseille, France; (P.-E.F.); (S.E.); (N.W.); (J.R.); (M.B.); (C.Z.); (V.F.); (D.R.)
- VITROME Unit, IRD, AP-HM, SSA, IHU-Méditerranée Infection, Aix Marseille University, 13005 Marseille, France
- Correspondence: ; Tel.: + 33-(0)-4-13-73-24-01; Fax: +33-(0)-4-13-73-24-02
| |
Collapse
|
|
2
|
Antibiotic resistance genes in the Actinobacteria phylum. Eur J Clin Microbiol Infect Dis 2019; 38:1599-1624. [PMID: 31250336 DOI: 10.1007/s10096-019-03580-5] [Citation(s) in RCA: 29] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2019] [Accepted: 05/01/2019] [Indexed: 02/07/2023]
Abstract
The Actinobacteria phylum is one of the oldest bacterial phyla that have a significant role in medicine and biotechnology. There are a lot of genera in this phylum that are causing various types of infections in humans, animals, and plants. As well as antimicrobial agents that are used in medicine for infections treatment or prevention of infections, they have been discovered of various genera in this phylum. To date, resistance to antibiotics is rising in different regions of the world and this is a global health threat. The main purpose of this review is the molecular evolution of antibiotic resistance in the Actinobacteria phylum.
Collapse
|